Topics in pediatric leukemia--acute lymphoblastic leukemia.
作者信息
Esparza Samuel D, Sakamoto Kathleen M
机构信息
Division of Pediatric Hematology and Oncology, Mattel Children's Hospital at the University of California at Los Angeles, USA.
出版信息
MedGenMed. 2005 Mar 7;7(1):23.
Abstract
摘要
相似文献
1
Topics in pediatric leukemia--acute lymphoblastic leukemia.
MedGenMed. 2005 Mar 7;7(1):23.
2
[Acute lymphoblastic leukemia (ALL)].
Nihon Rinsho. 2012 Apr;70 Suppl 2:670-5.
3
Biology and treatment of acute lymphoblastic leukemia.
Hematol Oncol Clin North Am. 2010 Feb;24(1):1-18. doi: 10.1016/j.hoc.2009.11.014.
4
Pediatric acute lymphoblastic leukemia: there is no TEL-ing what wonders lie ahead.
Leuk Res. 2010 Apr;34(4):418-9. doi: 10.1016/j.leukres.2009.10.009. Epub 2009 Nov 4.
5
T-Cell Lymphoblastic Lymphoma Showing Aberrant Synaptophysin Expression in a Child.
Turk J Haematol. 2020 Feb 20;37(1):72-73. doi: 10.4274/tjh.galenos.2019.2019.0307. Epub 2019 Dec 19.
6
[Molecular biology in childhood acute lymphoblastic leukemia (ALL)].
Rinsho Ketsueki. 2013 Oct;54(10):1999-2005.
7
Hematology clinic. Acute lymphoblastic leukemia.
Hematology. 2014 Jun;19(4):246-7. doi: 10.1179/1024533214Z.000000000281.
8
[Acute leukemias].
Rev Med Suisse. 2008 May 21;4(158):1272-4, 1276-8.
9
[Pathology of acute lymphoblastic leukemia].
Nihon Rinsho. 2012 Apr;70 Suppl 2:433-7.
10
[Progress in biology and therapy of acute lymphoblastic leukemia].
Postepy Hig Med Dosw. 1989;43(2-4):291-328.
引用本文的文献
1
Ethnicity modifies the association between microRNA single nucleotide polymorphisms and pediatric acute lymphoblastic leukemia risk: a meta-analysis.
Biomark Med. 2025 Jun;19(11):435-449. doi: 10.1080/17520363.2025.2511466. Epub 2025 May 29.
2
Metabolomic insights into pathogenesis and therapeutic potential in adult acute lymphoblastic leukemia.
Proc Natl Acad Sci U S A. 2025 Feb 18;122(7):e2423169122. doi: 10.1073/pnas.2423169122. Epub 2025 Feb 13.
3
Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in a Cohort of Hungarian Pediatric Patients with Hematological and Oncological Disorders: A Pilot Study.
Int J Mol Sci. 2024 Aug 14;25(16):8831. doi: 10.3390/ijms25168831.
4
Cytokine-induced killer cells: new insights for therapy of hematologic malignancies.
Stem Cell Res Ther. 2024 Aug 13;15(1):254. doi: 10.1186/s13287-024-03869-z.
5
Effect of sustained measurable residue disease negativity and post-remission treatment selection on the prognosis of acute lymphoblastic leukemia in adults.
Cancer Med. 2024 May;13(10):e7310. doi: 10.1002/cam4.7310.
6
Checkpoint Immunotherapy in Pediatric Oncology: Will We Say Checkmate Soon?
Vaccines (Basel). 2023 Dec 12;11(12):1843. doi: 10.3390/vaccines11121843.
7
Extracellular vesicle small RNA cargo discriminates non-cancer donors from pediatric B-lymphoblastic leukemia patients.
Front Oncol. 2023 Nov 13;13:1272883. doi: 10.3389/fonc.2023.1272883. eCollection 2023.
8
Cost-Effectiveness of Blinatumomab in Pediatric Patients with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia in France.
Pharmacoecon Open. 2023 Jul;7(4):639-653. doi: 10.1007/s41669-023-00411-4. Epub 2023 Apr 18.
9
Identification of Hub Genes Associated with Resistance to Prednisolone in Acute Lymphoblastic Leukemia Based on Weighted Gene Co-expression Network Analysis.
Mol Biotechnol. 2023 Nov;65(11):1913-1922. doi: 10.1007/s12033-023-00707-0. Epub 2023 Mar 6.
10
Renal Ultrasonographic Abnormalities at Initial Presentation of Children Diagnosed with Acute Lymphoblastic Leukemia and Long-Term Renal Functions and Prognosis in Survivors.
Sisli Etfal Hastan Tip Bul. 2022 Sep 22;56(3):421-426. doi: 10.14744/SEMB.2022.89646. eCollection 2022.
本文引用的文献
1
Trends in environmentally related childhood illnesses.
Pediatrics. 2004 Apr;113(4 Suppl):1133-40.
2
Emergency care: the tumor lysis syndrome.
Rev Med Chir Soc Med Nat Iasi. 2002 Oct-Dec;106(4):705-11.
3
Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?
Cancer Treat Rev. 2004 Feb;30(1):37-51. doi: 10.1016/S0305-7372(03)00140-3.
4
CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia: High-dose methotrexate versus cranial irradiation.
Pediatr Blood Cancer. 2004 Jan;42(1):24-9. doi: 10.1002/pbc.10392.
5
Gene expression profiling in childhood acute leukemia: progress and perspectives.
Int J Hematol. 2003 Dec;78(5):414-20. doi: 10.1007/BF02983813.
6
International collaboration on childhood leukemia.
Int J Hematol. 2003 Dec;78(5):383-9. doi: 10.1007/BF02983810.
7
Brighter future for children with T-ALL.
Lancet Oncol. 2003 Nov;4(11):650. doi: 10.1016/s1470-2045(03)01263-4.
8
Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia.
Br J Haematol. 2003 Nov;123(3):396-405. doi: 10.1046/j.1365-2141.2003.04584.x.
9
Flow cytometric detection of minimal residual disease in acute lymphoblastic leukemia.
Leuk Lymphoma. 2003 Sep;44(9):1445-55. doi: 10.3109/10428190309178763.
10
Results of therapy for acute lymphoblastic leukemia in black and white children.
JAMA. 2003 Oct 15;290(15):2001-7. doi: 10.1001/jama.290.15.2001.
Zotero 插件